PER
Click for more information
2.35% 8.3¢ percheron therapeutics limited

Ann: First approval for ATL1102 Phase IIb DMD clinical trial

  1. ASX News
    lightbulb Created with Sketch. 851
    clock Created with Sketch.
    14/02/23
    09:06
    Post #: 66228295
    Likes Created with Sketch. 38  Upvote
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
NEWS Finding properties tenants will want to rent
right-arrow Created with Sketch.
ALK Alkane Resources hit 57.2Kozpa gold production through FY24 – and eyeing 70Ktpa in FY26
right-arrow Created with Sketch.
ARU Cashed up Arafura locks in $171M German export agency deal; locks in NdPr offtake for wind turbines
right-arrow Created with Sketch.
A1M Swagman shoot proves plentiful for AIC, with Cu beyond 3% close to Eloise
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.3¢ 		Change
-0.002(2.35%) 		Mkt cap ! $75.72M
Open High Low Value Volume
8.4¢ 8.4¢ 8.3¢ $702 8.4K

Buyers (Bids)

No. Vol. Price($)
1 5500 8.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 26423 1
View Market Depth
Last trade - 11.08am 05/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.